Capelieva 500mg

Capelieva 500mg Tablet contains Capecitabine as its active ingredient. It falls under the category of antimetabolite medications. This drug is utilized alongside other anticancer therapies for treating metastatic colorectal cancer and breast cancer. Cancer is characterized by the abnormal and uncontrolled proliferation of cells. Additionally, it is employed to prevent the recurrence of cancer in the colon following the complete surgical removal of a tumor.

Common side effects associated with this medication include loss of appetite, headaches, runny nose, fever, hair loss, and dry mouth. While undergoing treatment with Capelieva 500mg Tablet, your physician may periodically check your complete blood counts, prothrombin time, and INR to avert serious complications. It is important to inform your doctor if you have a history of stomach ulcers, cataracts, lung disease, or any issues related to your heart, liver, skin, or kidneys. Notify your physician prior to any eye surgeries or dental procedures. Additionally, inform your doctor if you have experienced any allergic or unusual reactions after taking Capelieva 500mg Tablet. This medication may lead to fertility issues, so discuss any fertility concerns with your doctor before commencing treatment.

Capelieva 500mg Tablet is not advised for use in children and adolescents. Before starting this medication, consult your physician if you have a sugar intolerance, as this chemotherapy drug contains lactose. This medication should not be administered if you have a low white blood cell or platelet count, chickenpox, shingles, or a deficiency in the enzyme DPD (dihydropyrimidine dehydrogenase). It is recommended to take this medication within thirty minutes after completing a meal. Furthermore, this drug can cause fetal harm if given to a pregnant woman.